Breadcrumb Trail Links
An insurer has turned down Sara Aldrich's bid for coverage for Trikafta, described by an advocate as the single greatest innovation in cystic fibrosis history.
Author of the article:
Publishing date:
Sara Aldrich believes you cant put a price on life.
This advertisement has not loaded yet, but your article continues below.
But others are doing just that, and the value theyve assigned to hers is less than the cost of a recently approved drug, Trikafta, that could greatly improve and lengthen it.
Aldrich, a 23-year-old student and Stittsville resident, has cystic fibrosis, a progressive, degenerative multi-system disease that affects mainly the lungs and digestive system by creating a buildup of thick mucus, causing respiratory ailments and making digestion and the absorption of nutrients difficult.
There is no known cure, and in 2018 half of the deaths in Canada from CF involved people younger than 33.
Diagnosed at 16 months, Aldrich led an active lifestyle throughout her childhood and teens, playing competitive soccer. She fully recovered from a lung collapse when she was in Grade 11, but well recalls the warning a doctor at the hospital once offered, telling her to prepare for her death.
This advertisement has not loaded yet, but your article continues below.
Meanwhile, despite a rigorous daily regimen aimed at slowing further decline, Aldrichs lung function has dropped from between 80 and 90 per cent three years ago to the low 40s today. At this rate, she estimates shell be on the lung-transplant list within two years.
My dream is to run a marathon, she says, but, as of right now, even walking up the stairs, I usually cough so much that I throw up. I dont sleep through the night anymore. Im always exhausted. Im seeing myself decline very, very quickly, and we dont know how to put a stop to it. Ive had infection after infection.
Last June, however, CF patients in Canada were encouraged when Health Canada approved Trikafta, a drug that Kelly Grover, president and CEO of Cystic Fibrosis Canada, described as the single greatest innovation in cystic fibrosis history (with) the power to transform the lives of thousands of Canadians.
This advertisement has not loaded yet, but your article continues below.
While not a cure, Cystic Fibrosis Canadas Kim Steele says, its by far the closest thing yet.
We are seeing people who were on the lung transplant list go off the list and return to work or be able to raise children. In the U.S., theres been a baby boom because people with CF are in a spot where theyre thinking, Im healthy enough to have a child and Im going to be around for a while to care for that child.
Trikafta, she adds, has been transformational.
With an annual list price of about $300,000, though, the drug would otherwise be out of reach of all but the wealthiest, so many welcomed the news in September that Ontario was adding Trikafta to the provincial drug program.
Our government has taken urgent action to ensure all cystic fibrosis patients will have more timely access to the effective and life-changing treatments they need, Minister of Health Christine Elliott said.
This advertisement has not loaded yet, but your article continues below.
Because shes still in school, Aldrich was able to apply for coverage through her mothers Ontario Teachers Insurance Plan, or OTIP, benefits for which are paid through Manulife. But OTIP, and many other groups that administer benefits for employee health plans, employs FACET, an independent team of clinical pharmacists that reviews and approves, or denies, requests for specialty drug therapies.
Two weeks ago, Aldrich received an email from FACET, saying her application was denied. The letter cited a recent recommendation by the Canadian Drug Expert Committee (CDEC) of the Canadian Agency for Drugs and Technologies in Health (CADTH), indicating Trikafta was not cost-effective.
A 90% price reduction would be required for Trikafta to reach acceptable costeffectiveness thresholds, the letter read. As a result, the group benefits plan is unable to provide coverage for Trikafta at this time.
This advertisement has not loaded yet, but your article continues below.
Aldrich is, understandably, devastated.
You cant put a price on someones life, and right now it is a matter of life and death.
Imagine being told that theres this amazing drug thats going to save you and then have it ripped away from you.
Steele, meanwhile, is upset, noting that the recommendation from CADTH is a non-binding one intended for the countrys public payers, such as federal and provincial health plans, which take into consideration such factors as long-term hospitalizations and transplants.
Our governments pay for those, and they have decided this drug is worth funding because it has greater value than relegating people to hospital beds for the rest of their lives and shortening their lives, she says.
This advertisement has not loaded yet, but your article continues below.
So, when a private insurer has not moved to cover this, its a real problem because what theyre saying, essentially, is that the government can fund it and they dont have to, and thats shameful.
Additionally, Steele notes, governments typically dont pay the full list price for a drug, instead joining forces to negotiate a better, private deal.
Our governments were able to negotiate that price down, probably not 90 per cent, but somewhere in the middle. And, if our public payers can do that, the private insurers that charge premiums can. Its a total smokescreen, and people are paying into these private plans and not getting the benefits, not getting the drugs they need.
Steele admits theres no easy fix to what is a multi-layered problem, but points to the model used in Quebec, where mandated private insurance led to a cooperative risk-share model.
This advertisement has not loaded yet, but your article continues below.
She also suggests that private payers should be at the table with public ones when negotiating drug prices. Everybody has a bit to pay here, and, if we all put our money in the same pot, we can get better results and people can get the medicine that they need faster and in a more fulsome way.
Mike Sullivan, CEO of Cubic Health, which administers FACET, says the practice of provinces jointly negotiating private agreements with pharmaceutical companies, without insurance companies at the table, creates a two-tier pricing system for expensive drugs such as Trikafta.
(It) creates a very unbalanced playing field, he said in an email. The benefit plans have limited funding to provide all benefits (not just drug), and, if they have to pay multiples of what the public plans have to pay, they cannot cover the same breadth of medications.
This advertisement has not loaded yet, but your article continues below.
In the meantime, Aldrich weighs her options while her lung function worsens. She could apply to the provinces OHIP+ plan, but would have to forego any other coverage under her mothers benefits plan, while any coverage she might be approved for would end next year, when she turns 25. That would at least fill a gap, during which she hopes insurance companies will realize how important Trikafta is to CF patients.
Theres also the possibility that she and her brother Chris, who also has CF, might be able to get Trikafta through the Ontario Disability Support Program.
Weve been working pretty hard for me to get Trikafta because its pretty much my last hope, she says.
Without Trikafta, I dont really plan for my future because theres this fear that I wont have a future. But, with Trikafta, I see myself accomplishing the goals that Ive always set out for myself. Ive always had a passion to teach, and Ive always wanted a family that is my absolute dream. I know that, with Trikafta, I would be able to start a family and have a house and everything that you dream of as someone without CF. I see the potential in my life and living a long life.
This advertisement has not loaded yet, but your article continues below.
Sign up to receive daily headline news from Ottawa Citizen, a division of Postmedia Network Inc.
A welcome email is on its way. If you don't see it, please check your junk folder.
The next issue of Ottawa Citizen Headline News will soon be in your inbox.
We encountered an issue signing you up. Please try again
Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notificationsyou will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.
Continued here:
- Lowe's Teams Up with Lionel Messi, Inter Miami CF and CONMEBOL Copa Amrica 2024 USA to Win Over Soccer ... - Lowes Corporate - April 20th, 2024 [April 20th, 2024]
- Canyon Endurace CF SLX 8 AXS Aero All in the name of speed and distance? - GRAN FONDO Cycling Magazine - April 20th, 2024 [April 20th, 2024]
- Porosome treatment targeting CFTR shows promise in CF models - Cystic Fibrosis News Today - April 20th, 2024 [April 20th, 2024]
- The Reign of Girls Generation's YoonA in Endorsements: The CF Queen - allkpop - April 20th, 2024 [April 20th, 2024]
- Lowe's Teams Up with Lionel Messi, Inter Miami CF and CONMEBOL Copa Amrica 2024 USA to Win Over Ftbol ... - Inter Miami CF - April 20th, 2024 [April 20th, 2024]
- The changing epidemiology of pulmonary infection in children and adolescents with cystic fibrosis: an 18-year ... - Nature.com - April 20th, 2024 [April 20th, 2024]
- Controlling anxiety is a key part of managing my health with CF - Cystic Fibrosis News Today - April 20th, 2024 [April 20th, 2024]
- Orlando City at CF Montreal: Three Keys to Victory - The Mane Land - April 20th, 2024 [April 20th, 2024]
- Learn to Evaluate (CF) using the Charts - Stock Traders Daily - April 20th, 2024 [April 20th, 2024]
- CF Industries and JERA Announce Joint Development Agreement to Develop Greenfield Low-Carbon Ammonia ... - Business Wire - April 20th, 2024 [April 20th, 2024]
- CF Montreal plays Orlando City in conference action - FOX Sports - April 20th, 2024 [April 20th, 2024]
- CF Montral: What is the ceiling for Josef Martnez's new team? | MLSSoccer.com - MLSsoccer.com - April 20th, 2024 [April 20th, 2024]
- Spotlight on CF Industries Holdings: Analyzing the Surge in Options Activity - CF Industries Holdings (NY - Benzinga - April 20th, 2024 [April 20th, 2024]
- Mamardashvili boast the highest spot-kick saves this season - Valencia CF - April 20th, 2024 [April 20th, 2024]
- Jaume Domnech: "I have the VCF DNA inside me" - Valencia CF - April 20th, 2024 [April 20th, 2024]
- MATCH RECAP: Inter Miami CF Earns 2-3 Win on the Road Over Sporting Kansas City at a Packed Arrowhead Stadium - Inter Miami CF - April 20th, 2024 [April 20th, 2024]
- Pavel "The Experiment" Dailidko: Undefeated in 2023 and Charging into BRAVE CF 81 this Saturday, April 20 - Black Belt Magazine - April 20th, 2024 [April 20th, 2024]
- JERA and CF Industries Holdings sing ammonia production deal - SAFETY4SEA - April 20th, 2024 [April 20th, 2024]
- Lowe's Teams Up with Lionel Messi, Inter Miami CF and CONMEBOL Copa Amrica 2024 USA to Win Over Soccer ... - PR Newswire - April 20th, 2024 [April 20th, 2024]
- CF Industries Holdings, Inc. (NYSE:CF) Shares Purchased by Mirae Asset Global Investments Co. Ltd. - Defense World - April 20th, 2024 [April 20th, 2024]
- CF: Milan to jump above Juventus in UEFA ranking for first time in 10 years - Sempre Milan - April 20th, 2024 [April 20th, 2024]
- Color Star's Partner Team Villarreal CF Bests Real Madrid CF Once Again As The Yellow Submarine Maintains Its Impressive Win Record -... - April 19th, 2023 [April 19th, 2023]
- Brave CF 70 Slovenia: Joilton Lutterbach vs. Andreas Gustafsson; Date, fight times, how to watch on DAZN - dazn.com - April 19th, 2023 [April 19th, 2023]
- Malaga CF owner Sheikh Al-Thani vows never to put the club he has run into the ground up for sale - The Olive Press - April 19th, 2023 [April 19th, 2023]
- CF Industries partnering with South Korea firm on $2 billion blue ammonia project in Ascension - The Advocate - March 4th, 2023 [March 4th, 2023]
- Cystic Fibrosis (CF): Causes, Symptoms, Diagnosis & Treatment - February 7th, 2023 [February 7th, 2023]
- Reg CF: 2022 Delivered A Decline For Investment Crowdfunding As Economy Slowed, But Expectations Going - Crowdfund Insider - February 7th, 2023 [February 7th, 2023]
- Cystic fibrosis life expectancy: Averages by stage and age - February 2nd, 2023 [February 2nd, 2023]
- Cystic Fibrosis Carrier: What You Should Know - Healthline - February 2nd, 2023 [February 2nd, 2023]
- Cystic Fibrosis: Prenatal Screening and Diagnosis | ACOG - February 2nd, 2023 [February 2nd, 2023]
- CF Moto to launch a retro mini bike, will compete with Honda Grom in the international markets, all we know so far - DNP INDIA - February 2nd, 2023 [February 2nd, 2023]
- CF Industries Holdings, Inc. (NYSE:CF) Short Interest Down 10.3% in October - MarketBeat - November 16th, 2022 [November 16th, 2022]
- Will CF Industries Holdings, Inc. (CF) Stay at the Top of the Basic Materials Sector? - InvestorsObserver - October 25th, 2022 [October 25th, 2022]
- Wanyama on Sunday played his last match for CF Montreal- Here are potential destinations - The Standard - October 25th, 2022 [October 25th, 2022]
- Scouting Report: 5 things you should know about CF Montral when they play NYCFC in the MLS Cup Playoffs - Hudson River Blue - October 21st, 2022 [October 21st, 2022]
- 2-year-old living with cystic fibrosis helped by new treatments - 11Alive.com WXIA - October 13th, 2022 [October 13th, 2022]
- Phage Trial to Treat CF Patients with Multi-Drug Resistant Bacterial Infections - UC San Diego Health - October 13th, 2022 [October 13th, 2022]
- High Blood-sugar Levels at Night Affect Lung Function in CF Adults... - Cystic Fibrosis News Today - October 13th, 2022 [October 13th, 2022]
- This 7-year-old is finally on a 'life-changing' cystic fibrosis drug. For others in Ontario, access is tricky - CBC.ca - October 13th, 2022 [October 13th, 2022]
- CF's Thomas and Easttam dodge Panthers' high-powered defense, tackle running offense head-on - Camden News - October 13th, 2022 [October 13th, 2022]
- The Difficulties of Diving Back In After Taking a Hiatus | Cystic... - Cystic Fibrosis News Today - October 13th, 2022 [October 13th, 2022]
- Cystic Fibrosis Market to Showcase Growth at a CAGR of 9% During the Forecast Period (2022-2032) | DelveInsight - PR Newswire - October 13th, 2022 [October 13th, 2022]
- Massive Predictions: Columbus Crew at CF Montral - Massive Report - September 9th, 2022 [September 9th, 2022]
- Why CF Acquisition Corp. VI Blasted 14% Higher Today - The Motley Fool - September 9th, 2022 [September 9th, 2022]
- Watch Real Betis vs. Villarreal CF Online: Live Stream, Start Time - For The Win - September 9th, 2022 [September 9th, 2022]
- Watch Getafe CF vs. Real Sociedad Online: Live Stream, Start Time - For The Win - September 9th, 2022 [September 9th, 2022]
- Mauro Icardi linked with move to Inter Miami CF - AS USA - September 9th, 2022 [September 9th, 2022]
- CF Acquisition (NASDAQ:CFVI) Rumble Takes On Traditional Media Outlets With New 'Rumble Exclusives' Liv - Benzinga - September 9th, 2022 [September 9th, 2022]
- SF Giants CF struggles on triple by Klay's brother - SFGATE - July 25th, 2022 [July 25th, 2022]
- CF Industries Holdings, Inc. Statement Regarding ITC Injury Determination Concerning Imports of UAN from Russia and Trinidad and Tobago - Business... - July 25th, 2022 [July 25th, 2022]
- CF man jailed in hit-and-run case - Leader-Telegram - July 25th, 2022 [July 25th, 2022]
- AEG and Socios.com Launch Partnership for the Inaugural Soccer Champions Tour Featuring Real Madrid CF, FC Barcelona, Juventus, Club America and Club... - July 25th, 2022 [July 25th, 2022]
- Taty Castellanos plays his final game for NYCFC in 2-0 home win - Hudson River Blue - July 25th, 2022 [July 25th, 2022]
- Padres' Fernando Tatis Jr.: Position Change to CF from SS 'Not out of the Question' - Bleacher Report - July 25th, 2022 [July 25th, 2022]
- CF Industries Stock: From Boom To Bust - Sell Into The Rallies (NYSE:CF) - Seeking Alpha - June 20th, 2022 [June 20th, 2022]
- CF graduates to chart their own paths to success - Valley Breeze - June 20th, 2022 [June 20th, 2022]
- Poirier: We need the strength of the fans" - Real Madrid CF - June 20th, 2022 [June 20th, 2022]
- Vertex to Present Data Demonstrating Significant Benefits of Long-Term and Early Treatment With CFTR Modulators at the European Cystic Fibrosis... - June 11th, 2022 [June 11th, 2022]
- Jayda Coleman, Oklahoma CF, robs Texas of a home run at the wall - Saturday Down South - June 11th, 2022 [June 11th, 2022]
- Gennaro Gattuso brings tenacity and technique to the Valencia CF dugout - Yardbarker - June 11th, 2022 [June 11th, 2022]
- 77-85: On to the league final - Real Madrid CF - June 11th, 2022 [June 11th, 2022]
- Gator Greats On CF Hall of Fame Ballot - ESPN 98.1 FM - 850 AM WRUF - WRUF - June 11th, 2022 [June 11th, 2022]
- Mariners CF Julio Rodrguez named AL Rookie of the Month for May - Seattle Sports - June 5th, 2022 [June 5th, 2022]
- CF woman charged with theft of trade secrets from former employer - Leader-Telegram - June 5th, 2022 [June 5th, 2022]
- Laso: The team were magnificent in defense" - Real Madrid CF - June 5th, 2022 [June 5th, 2022]
- The Austrian Wonderboy Returns To Action At BRAVE CF 59 in Uzbekistan - FightBook MMA - June 5th, 2022 [June 5th, 2022]
- Son Ye Jin Teases Fans With First CF Since Wedding to Hyun Bin - Kdramastars - June 5th, 2022 [June 5th, 2022]
- Fourth anniversary of the Duodcima - Real Madrid CF - June 5th, 2022 [June 5th, 2022]
- Meet the Avro CF-105 Arrow: The Long-Ranger Fighter Designed to Battle Russia - 19FortyFive - June 5th, 2022 [June 5th, 2022]
- Charlottetown to host professional soccer match between Sunderland AFC, CF Montral U23 teams - Saltwire - June 5th, 2022 [June 5th, 2022]
- Neutrophil Dysfunction in the Pathogenesis of Cystic Fibrosis (CF) - Physician's Weekly - May 21st, 2022 [May 21st, 2022]
- CF Industries Holdings, Inc. (NYSE:CF) Expected to Announce Earnings of $6.16 Per Share - Defense World - May 21st, 2022 [May 21st, 2022]
- Living with Cystic Fibrosis: A CF patient experience story | LHSC - London Health Sciences Centre - May 21st, 2022 [May 21st, 2022]
- CF Montreals Ismal Kon is showing impressive promise early this MLS season - The Athletic - May 21st, 2022 [May 21st, 2022]
- Film produced by CF native to be shown at Micon Cinemas - Leader-Telegram - May 21st, 2022 [May 21st, 2022]
- CF & CFRP Market Research Report by Carbon Fiber Materials, Resin Type, Manufacturing Process, End-use Industry, Region - Global Forecast to 2027... - May 21st, 2022 [May 21st, 2022]
- Experienced defensive backs for CF thriving this off-season - Camden News - May 21st, 2022 [May 21st, 2022]
- The 37th anniversary of Real Madrid's first UEFA Cup - Real Madrid CF - May 21st, 2022 [May 21st, 2022]
- Q&A: How a Cystic fibrosis diagnosis has changed in recent years - WRAL News - May 6th, 2022 [May 6th, 2022]
- Kinnear: Hope, Turning CF Into 'Cure Found' and Betting on the Long Shot - insidelacrosse.com - May 6th, 2022 [May 6th, 2022]